The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

Investors Mutual’s Daniel Moore says there aren’t too many ASX-listed companies like blood plasma giant CSL that can compound ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks ...

Tech unicorn Atlassian reported $200 million in research and development expenditure in 2021-2022, topping the inaugural ATO ...

CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence (RWE) studies, highlighting the important role influenza vaccination plays in protecting public ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Biofund IV raised EUR 140 million in first closing of EUR 250 million fundBiofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investmentsFirst three investments of the new ...

Storey covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals Ltd., Polynovo Limited, and CSL. Currently, the analyst consensus on CSL is a Strong Buy with an average price ...

AFIC has been actively buying these stocks. The post These are the ASX blue-chip shares this big Aussie fund has been buying ...